MedPath

Study held to see the effect of intake of Karkotimool powder in the treatment of Renal calculi.

Phase 2
Conditions
Health Condition 1: N29- Other disorders of kidney and ureter in diseases classified elsewhere
Registration Number
CTRI/2020/12/029507
Lead Sponsor
DR JITENDRA KUMAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Size of calculus- A known diagnosed case having renal calculus upto 8 mm.

2)Age group -18 to 60 years with irrespective of gender.

3)Patient of C/O-Udarshool (pain in abdomen), Sadah Mootra Pravrutti (Burning Micturition), Sarakta Mootra Pravrutti (hematuria) will be included.

4)Patients of either sex are taken irrespective of caste, religion and socio-economic status.

5)Though Patients having Mild to Moderate Hydronephrosis will be included in study

( e. Up to the Grade 3 of Hydronephrosis).

Exclusion Criteria

1)Age: below 18 and above 60 years.

2)Systemic diseases like malignancy,Kochââ?¬•s patients and medico-renal disease (M.R.D.) patient.

3)Renal failure, congenital disorder like ectopic kidney, horse shoe kidney, stricture at UV and PU junction, neoplasm.

4)Patients having severe Hydronephrosis/more than mild to moderate (i.e. Grade 4 of Hydronephrosis).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Mootrashmari is a disease, identified as a global problem. It is a frequent clinical problem with an incidence of 0.1% to 6% in general population. <br/ ><br>2)To evaluate and establish safer,cost-effective Karkotimool choorna in the management of Mootra ashmari(Renal Calculi). <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 15 Days Study <br/ ><br>(0,7,15 days) <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Karkotimool choorna is the effective management of Mootrasmari(Renal Calculi)Timepoint: 15 Days with 3 follow up <br/ ><br>(0,7,15 days) <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath